The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...

Prediabetes is an extremely heterogeneous metabolic disorder. Scientists from several partner institutes of the German Center ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic mutations—IDH2 and SRSF2—work cooperatively to mis-splice RNA messages and ...

Background RNA 5-methylcytosine (m5C) has emerged as a critical epigenetic regulator in cancer biology, yet its role in the tumour immune microenvironment (TME) remains incompletely understood.

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the preparation ...

Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by remarkable cellular ...

New Study Reveals How Hypoxia Reprograms RNA Methylation to Promote Malignancy in Liver Cancer Hepatocellular carcinoma (HCC) ...

The company's 6-base sequencing solution integrates additional methylation signals, delivering an AUC of 0.95 for stage I CRC from liquid biopsy biomodal, an omics-based life sciences technology and ...

New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...

Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the ...